As we previously reported, May 11th ended COVID enforcement discretion affecting telemedicine. Supporting that, the Substance Abuse and Mental Health Services Administration (SAMHSA) along with the Drug Enforcement Agency announced a six-month temporary Rule to expand the circumstances under which individual practitioners can provide continuous medical treatment or withdrawal management treatment via a telemedicine encounter.
As we are not providing legal advice, we recommend any covered entity or business associate affected by SAMHSA / 42 CFR review any final Rule published by either agency and keep abreast of any other changes affecting telemedicine. Click the link below to read the temporary Rule.
Stay (HIPAA) safe, Alan -